他更进一步透露公司清晰的取证路径:"今年年底可能春节前我们还可以拿到多一点，明年我们还计划要拿到两个三类证。我们一直在一步一个脚印在往前 走。" 在产业政策的宏观引领、金融活水的持续支撑与市场主体的创新实践等共同作用下，中国医疗器械行业生态正发生结构性变化。行业主旋律已从规模扩 张，转向以"创新驱动"、"国产替代"、"出海布局"为核心的全面崛起。 在这样的背景下，今海医疗作为国内微创手术领域的深耕者，其发展路径与战略思考为我们提供了一个观察行业演进的样本。根据其管理团队与合作伙伴 在近期一次专访中的阐述，我们得以勾勒出这家公司的真实轮廓。 "默然潜行"与"证"明一切，被低估的硬核壁垒 "我们一直在默默耕耘，从2021年我们转型开始，累计已取得13份中国医疗器械注册证。"在这次与今海医疗团队及其合作伙伴的线上专访中，董事长陈国 宝先生用最朴实的语言道出了公司转型以来的核心成果。 在医疗监管的深水区，这绝非简单的纸面成绩。每一张注册证的背后，都是一套完整的研发、临床、质控和生产体系，是穿越了监管丛林后获得的"技术 通行证"。今海能够在转型的短短三年内获得13份中国医疗器械注册证，足以证明公司研发体系与质量管理体系 ...

作者 | 贝隆行业研究 数据支持 | 勾股大数 据（www.gogudata.com） 在产业政策的宏观引领、金融活水的持续支撑与市场主体的创新实践等共同作用下，中国医疗器械行业生态正发生结构性变化。 行业主旋律已 从规模扩张，转向以"创新驱动"、"国产替代"、"出海布局"为核心的全面崛起。 在这样的背景下，今海医疗作为国内微创手术领域的深耕者，其发展路径与战略思考为我们提供了一个观察行业演进的样本。根据其管理团队 与合作伙伴在近期一次专访中的阐述，我们得以勾勒出这家公司的真实轮廓。 "我们一直在默默耕耘，从2021年我们转型开始，累计已取得13份中国医疗器械注册证。"在这次与今海医疗团队及其合作伙伴的线上专访 中，董事长陈国宝先生用最朴实的语言道出了公司转型以来的核心成果。 他更进一步透露公司清晰的取证路径:"今年年底可能春节前我们还可以拿到多一点，明年我们还计划要拿到两个三类证。我们一直在一步一个 脚印在往前走。" 在医疗监管的深水区，这绝非简单的纸面成绩。 每一张注册证的背后，都是一套完整的研发、临床、质控和生产体系，是穿越了监管丛林后获 得的"技术通行证"。 今海能够在转型的短短三年内获得13份中国医 ...

Jinhai Medical Technology Limited 今海醫療科技股份有限公司 （於開曼群島註冊成立的成員有限責任公司） （股份代號：2225） 更改香港主要營業地點 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 承董事會命 今海醫療科技股份有限公司 董事會主席兼執行董事 陳國寶 香港，二零二五年十一月十八日 於本公告日期，董事會由八名董事組成，其中三名執行董事為陳國寶先生、王振飛 先生及李雲平先生；兩名非執行董事為蔣江雨先生及王華生先生；及三名獨立非 執行董事為嚴健軍先生、范一民先生及楊美華女士。 今海醫療科技股份有限公司（「本公司」）董事（「董事」）會（「董事會」）宣佈，自二 零二五年十一月十九日起，本公司香港主要營業地點將更改為「香港灣仔告士打 道178號華懋世紀廣場20樓2002室」。本公司電話及傳真號碼、電郵及網站均維持不 變。 ...

Core Insights - The collaboration between Jin Hai Medical Technology Co., Ltd. and Medtronic Kanghui marks a significant advancement in the field of spinal minimally invasive surgery through the launch of the "navigation-based spinal endoscopic minimally invasive technology" [1][3][4] Group 1: Technology Integration - The newly launched technology integrates Jin Hai Medical's advanced spinal endoscopic system with Medtronic Kanghui's locally developed "Qinghang™ EngineNav™ spinal surgical navigation system," enabling visual guidance and standardized operations throughout the surgical process [3][4] - This integration aims to enhance surgical efficiency and precision while significantly reducing surgical trauma and shortening patient recovery times, addressing the urgent clinical demand for minimally invasive and intelligent surgical solutions [3][4] Group 2: Ecosystem Development - The partnership signifies a shift in China's medical technology landscape from being a "follower" to a "co-creator," showcasing Jin Hai Medical's expertise in spinal endoscopy to enhance Medtronic Kanghui's product offerings and clinical service capabilities [4][8] - This "dual empowerment" approach is expected to break through resource and technology boundaries in the global spinal minimally invasive field, advancing towards a higher dimension of "system services" [4] Group 3: Ongoing Engagement - The collaboration will continue to engage at the COA conference until November 14, featuring multiple academic activities focused on cutting-edge topics such as "visible correction art," "precision breakthroughs in 'life danger zones'," and "comprehensive solutions for spinal minimally invasive endoscopy" [6] - These activities will provide a high-quality platform for communication among experienced experts and clinical doctors regarding the latest applications and values of navigation and endoscopic technologies in complex spinal surgeries [6] Group 4: Future Vision - Jin Hai Medical is committed to fostering innovation within an open and collaborative ecosystem, aiming to accelerate the adoption of "navigation-based spinal endoscopic minimally invasive technology" across China and globally [8] - The company plans to continue its partnership with Medtronic Kanghui and other global partners to ensure that the principles of "more minimally invasive, more intelligent, and more precise" surgeries benefit a larger patient population [8]

Core Insights - The collaboration between Jin Hai Medical (02225.HK) and Medtronic Kanghui marks a significant milestone with the launch of the "Navigation-based Spinal Endoscopy Minimally Invasive Technology" [1] - This technology integrates Jin Hai Medical's spinal endoscopy system with Medtronic Kanghui's "Qinghang™" surgical navigation system, aiming to advance spinal surgery towards a new phase of "visualization, precision, and minimally invasiveness" [1] - The event is part of the "New Thinking, Shared Moments" series, which includes multiple technical sharing sessions to showcase the strategic upgrade from "single-point innovation" to "system service" [1]

Core Viewpoint - The stock of Jianghai Medical Technology (02225.HK) has seen a significant increase, rising over 13% and currently trading at 1.29 HKD with a trading volume of 13.0365 million HKD [2] Company Summary - Jianghai Medical Technology's stock price increased by 5.74% at the time of reporting [2] - The total trading volume reached 13.0365 million HKD, indicating active market participation [2]

Core Viewpoint - Jin Hai Medical Technology (02225) has seen a significant stock increase of over 13%, currently trading at 1.29 HKD with a transaction volume of 13.0365 million HKD, following the announcement of a strategic cooperation framework agreement with Medtronic for the promotion of real-time navigation tracking endoscopic spine technology in China [1] Group 1: Strategic Cooperation - Jin Hai Medical Technology's subsidiary, Jin Hai Shanghai, has entered into a strategic cooperation framework agreement with Medtronic Changzhou to develop a leading domestic and internationally advanced integrated solution for navigation endoscopic spine technology [1] - The agreement aims to address clinical needs and will involve resource investment for domestic and international academic exchange activities to promote the clinical academic exchange and technological advancement of real-time navigation tracking endoscopic spine technology in China [1] - Both parties will provide navigation endoscopic spine prototypes for clinical demonstrations, training, and marketing activities to support the testing and evaluation of the technology [1] Group 2: Upcoming Events - The 8th China International Import Expo (CIIE) will be held in Shanghai from November 5 to 10, during which Jin Hai Medical Technology will jointly launch the latest developed navigation endoscopic spine innovation technology with Medtronic China [1] - This new technology is expected to be applicable in spinal surgery, paving the way for precision and intelligent development in spinal procedures, while also shortening the learning curve for clinicians in endoscopic spine technology [1] - The initiative is anticipated to facilitate more efficient and widespread clinical applications in the future [1]

Core Viewpoint - Jinhai Medical Technology (02225) has seen a significant stock increase of over 13%, currently trading at 1.29 HKD, with a transaction volume of 13.0365 million HKD, following the announcement of a strategic cooperation framework agreement with Medtronic for the promotion of real-time navigation tracking endoscopic spine technology in China [1] Group 1: Strategic Cooperation - Jinhai Medical Technology's subsidiary, Jinhai Shanghai, has entered into a strategic cooperation framework agreement with Medtronic Changzhou to develop a leading domestic and internationally advanced integrated solution for navigation endoscopic spine technology [1] - The partnership aims to address clinical needs, organize domestic and international academic exchange activities, and promote the clinical academic exchange and technological advancement of real-time navigation tracking endoscopic spine technology in China [1] - Both parties will provide navigation endoscopic spine prototypes for clinical demonstrations, training, and marketing activities to support the testing and evaluation of the technology [1] Group 2: Upcoming Events - The 8th China International Import Expo (CIIE) will be held in Shanghai from November 5 to 10, during which Jinhai Medical Technology will jointly launch the latest developed navigation endoscopic spine innovation technology with Medtronic China [1] - This new technology is expected to be applicable in spinal surgery, paving the way for precision and intelligent development in spinal procedures, while also shortening the learning curve for clinicians in endoscopic spine technology [1] - The initiative is anticipated to facilitate more efficient and widespread clinical applications in the future [1]

Company News - BeiGene reported total revenue of approximately $3.845 billion for the first nine months, a year-on-year increase of 43%. Adjusted net profit was approximately $693 million, marking a return to profitability. In Q3, revenue reached $1.412 billion, up 41% year-on-year, with adjusted net profit of approximately $304 million, a 489% increase year-on-year. The growth is primarily attributed to the sales increase of BeiYueZe® in the US and Europe, with the US remaining the largest market for the company. The full-year revenue guidance is set at $5.1 billion to $5.3 billion, reflecting strong growth expectations from BeiYueZe® in the US and continued expansion in Europe and other key global markets [2] - Yidu International Holdings announced an earnings upgrade, expecting a profit attributable to shareholders of approximately HKD 1.2 billion for the first half, representing an increase year-on-year [3] - Hua Hong Semiconductor reported sales revenue of $635 million for Q3 2025, a year-on-year increase of 20.7%. However, net profit decreased by 42.6% to $25.725 million [4] - Autohome's net profit attributable to the parent company for Q3 was approximately RMB 436.6 million, with online marketing and other business revenues increasing by 32.1% year-on-year [5] - Xinyi International reported a cumulative net operating income of approximately HKD 13.981 billion for the first ten months, a year-on-year decrease of about 5.3%, with October revenue at HKD 1.457 billion [6] - Dongfeng Motor Group's cumulative vehicle sales for the first ten months reached 1.501 million units, a year-on-year decline of approximately 1.6%. However, sales of new energy vehicles increased by approximately 37.1% to 421,400 units [7] - China Overseas Land & Investment reported a cumulative contracted property sales amount of approximately RMB 189.165 billion for the first ten months, a year-on-year decrease of 21.3% [8] - Poly Property Group reported a cumulative contracted sales amount of RMB 43.8 billion for the first ten months, a year-on-year decrease of 10.43% [9] - Gemdale reported a cumulative contracted sales amount of approximately RMB 9.125 billion for the first ten months, a year-on-year decrease of 43.93% [10] - Sunac China reported a cumulative contract sales amount of approximately RMB 32.77 billion for the first ten months, a year-on-year decline of 25.1% [11] - Guoyin Financial Leasing plans to purchase 1,198 units of domestic information technology computing equipment for a total consideration of RMB 1.04 billion [12] - Youjia Innovation recently received project designation notifications from a globally renowned automotive group's joint venture and luxury brand, with a total order amount of approximately RMB 320 million [13] - Swire Properties reported a rental rate of 96% for Taikoo Place in Q3, with a rental reduction of 13%. Other Swire properties had an occupancy rate of 90%, with a rental reduction of 15% [14] - Zhongshen Construction Industry plans to acquire 100% equity of Huajian Development Co., Ltd. for approximately HKD 213.6 million [15] - Hard Egg Innovation signed a memorandum of understanding with Huixin Investment to jointly develop an AIoT innovation enterprise incubation platform [16] - Damai Entertainment expects mid-term net profit to increase to no less than RMB 500 million, compared to RMB 337 million last year [17] - Cafe de Coral Group issued a profit warning, expecting mid-term profit attributable to shareholders to decline by 65% to 70% [18] - Qingci Games signed a game licensing transfer agreement with Disney, obtaining authorization to develop and publish the game "Disney: Book of Legends," expected to launch in 2026 across various regions [19] - Now Medical Technology's subsidiary signed a strategic cooperation framework agreement with Medtronic Changzhou to promote clinical applications of real-time navigation tracking endoscopic technology in China [19] - Zhaoke Ophthalmology-B signed a distribution agreement with PT FERRON for the commercialization of BRIMOCHOL PF in Indonesia, receiving an upfront payment and potential milestone payments [19] - Shoujia Technology signed a strategic framework cooperation agreement with Stardust Intelligence, covering the development of humanoid robot tendon and related fields [20] Buyback Dynamics - Helen's decided to exercise its share buyback authorization, planning to repurchase up to 127 million shares [21] - China Feihe repurchased 6.806 million shares for a total of approximately HKD 29.4298 million, with a buyback price of HKD 4.29 to HKD 4.35 [22] - Kintor Pharmaceutical repurchased 1.734 million shares for a total of approximately HKD 26.3078 million, with a buyback price of HKD 14.35 to HKD 15.8 [23] - COSCO Shipping Holdings repurchased 1.53 million shares for a total of approximately HKD 20.9869 million, with a buyback price of HKD 13.57 to HKD 13.84 [24] - Sinopec repurchased 2.398 million H-shares for a total of approximately HKD 10.1066 million, with a buyback price of HKD 4.20 to HKD 4.23 [25]

Core Insights - Company Jin Hai Medical Technology (02225) has announced a strategic cooperation framework agreement with Medtronic's indirect wholly-owned subsidiary, Medtronic Changzhou Medical Devices Co., Ltd. [1] Group 1: Strategic Cooperation Details - The agreement aims to develop a leading domestic and internationally advanced integrated solution for real-time navigation tracking spinal endoscopy based on clinical needs [1] - The parties will invest resources to organize domestic and international academic exchange activities to promote clinical academic exchange and technological advancement of real-time navigation tracking spinal endoscopy technology in China [1] - They will mutually provide spinal endoscopy prototypes for clinical demonstrations, training, and marketing activities to support the testing and evaluation of real-time navigation tracking spinal endoscopy technology [1]